Gladstone Institutional Advisory’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Gladstone Institutional Advisory’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-73,464	Closed	-$2.92M	–	701
2023 Q3	$2.92M	Buy	+73,464	New	+$3.11M	0.19%	139

Other funds holding XPH

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Gladstone Institutional Advisory's XPH Position: Q4 2023 in Review

Gladstone Institutional Advisory sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2023, closing a stake of 73,464 shares — an estimated $2.92M sold.

Gladstone Institutional Advisory first reported a position in XPH in Q3 2023 and held it in 1 quarter. The position peaked at $2.92M in Q3 2023. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2023.

Gladstone Institutional Advisory reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2023 after selling out during the quarter.
Gladstone Institutional Advisory sold 73,464 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2023, an estimated $2.92M.
Gladstone Institutional Advisory first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2023 and held it in 1 quarter.
Gladstone Institutional Advisory's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.92M in Q3 2023.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2023.

Based on Gladstone Institutional Advisory's 13F filing for Q4 2023, filed 9 Feb 2024.